 RESEARCH TRIANGLE PARK, N.C., Aug. 26, 2021 GLOBE NEWSWIRE -- BioCryst Pharmaceuticals, Inc. Nasdaq:BCRX today announced that the company has appointed former director of the U.S. Food and Drug Administration FDA Center for Drug Evaluation and Research CDER, and former acting surgeon general, Steven Galson, M.D., MPH to its board of directors. 